Notice to Readers
International Symposium
on Tuberculosis Vaccine Development and Evaluation
The 1998 International Symposium on Tuberculosis Vaccine
Development
and Evaluation will be held August 26-28, 1998, in San Francisco,
California. The symposium, cosponsored by ÐÇ¿ÕÓéÀÖ¹ÙÍø's National Vaccine
Program
Office, the National Institute of Allergy and Infectious Diseases,
the
American Lung Association, the World Health Organization, the
American
Thoracic Society, and the International Union Against Tuberculosis
and Lung
Disease, is for scientists, public health practitioners, infectious
disease
and pulmonary physicians, other health-care providers, vaccine
manufacturers and distributors, and biotechnology firms. Symposium
topics
will include public health implications of tuberculosis (TB), the
status of
TB vaccine development, preclinical obstacles for TB candidate
vaccines,
challenges in TB vaccine evaluation, strategies for overcoming
barriers for
field testing, and criteria for field site selection. Information
on the
symposium is available from ÐÇ¿ÕÓéÀÖ¹ÙÍø's National Vaccine Program Office,
telephone (404) 639-4168.
Disclaimer
All MMWR HTML versions of articles are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the electronic PDF version and/or the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.
**Questions or messages regarding errors in formatting should be addressed to [email protected].
